Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CD3D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
C1QTNF4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC102724993 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MMP15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM259 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FGF3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCRT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MED25 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
POLR2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DCAF15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CNTROB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101930075 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SOX18 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HIRA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VSX1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RECK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IQCC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RTEL1-TNFRSF6B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on